Skip to main content

Topic

Obviousness

205 published works

  1. ILN IP Insider

    BLOCKING PATENTS CAN MOOT OBJECTIVE INDICIA OF NON-OBVIOUSNESS

    In a recent precedential decision, a split Federal Circuit (Judges Dyk and Taranto in the majority, Judge Newman, dissenting) issued a lengthy, 53-page decision, regarding the obviousness doctrine.  Judge Taranto,…

  2. Prosecution First Blog

    Informative One Day, Non-Informative the Next

    By James D. Stein Stacy Lewis

    PTAB Decision:  Ex parte Jung, Appeal No. 2016-008290 (P.T.A.B. March 22, 2017) Background:  The USPTO designated Ex parte Jung, Appeal No. 2016-008290 (P.T.A.B. March 22, 2017), as “informative” on July…

  3. PTABWatch

    PTAB Was Wrong to Ignore an Applicant’s Prosecution Disclaimer Because of Examiner’s Reasons for Allowance

    By Marshall Gerstein

    Despite disagreeing with the PTAB’s preferred claim construction, the Federal Circuit in Arendi S.A.R.L. v. Google LLC, Case No. 2016-1249 (Fed. Cir. Feb. 20, 2018) nevertheless determined that the PTAB…

  4. Life Science Legal Report

    Hindsight Is Not 20/20: PTAB Technology Center 1600 Decision Round-Up: Week of May 28 – June 1, 2018

    By Allison M. Glasunow

    At the end of a week shortened by the Memorial Day holiday, the PTAB (“Board”) issued just two decisions in Technology Center (TC) 1600 during the week of May 28. …

  5. PTAB Law Blog

    How Creative is One of Ordinary Skill – DSS Tech. Mgmt. v. Apple Inc.

    By John D. Higgins

    In an attempt to challenge the patentability of an issued claim, petitioners every so often come across a prior art reference that discloses all the recited features of the claim…

  6. PTABWatch

    Rituxan Patent Spared by Failure to Establish Product Label as “Printed Publication”

    By Heather R. Kissling

    A patent relating to a method of treating rheumatoid arthritis using rituximab recently survived its fourth IPR challenge. Celltrion, Inc. v. Biogen, Inc., IPR2016-01614 (PTAB Feb. 21, 2018). The PTAB…

  7. PTABWatch

    Petitioner Failed to Show That Patent Owner’s Drug Product Package Insert Was a Printed Publication

    By Eric M. Brusca, Ph.D.

    On February 9, 2018, the PTAB denied Sandoz Inc.’s petition for inter partes review of U.S. Patent No. 9,512,216, a patent owned by AbbVie Biotechnology Ltd. The patent recites methods…

  8. PTABWatch

    PTAB Gets A Math Lesson

    By William K. Merkel, Ph.D.

    In Shinn Fu Co. of America, Inc. v. The Tire Hanger Corp., Dkt. No. 2016-2250 (Fed. Cir. July 3, 2017), Shinn Fu appealed the Board’s holding in IPR2015-00208 (discussed here),…

  9. PTAB Law Blog

    Federal Circuit Revives Polaris’ Claims After PTAB’s Obviousness Analysis Veers Off Course

    By Aydin H. Harston

    On February 9, 2018, in vacating and remanding parts of an obviousness decision, the Federal Circuit found that the Patent Trial and Appeal Board (“PTAB” or “the Board”) erred in…

  10. PTABWatch

    PTAB Should Have Considered Argument Raised in “Redundant,” Non-instituted Ground

    By Michael R. Weiner

    In CRFD Research Ltd. v. Matal, No. 2016-2198 (Fed. Cir. Dec. 5, 2017), the Federal Circuit determined that the PTAB erred in its obviousness analysis, in part by failing to…